Market Currents
Argus lines up United Therapeutics (UTHR -1.4%) as an undervalued name in the healthcare sector,...
-
Tuesday, March 20, 2012, 3:49 PM ETArgus lines up United Therapeutics (UTHR -1.4%) as an undervalued name in the healthcare sector, as it maintains a Buy rating on the biotech concern. Analysts with the firm expect Argus to hit its 2012 sales target, as they raise their price target on shares by $8 to $60.
Other date
Latest Articles
